Literature DB >> 2437433

Strain differences of interferon-generating capacity and resistance in toxoplasma-infected mice.

T Shirahata, A Mori, H Ishikawa, H Goto.   

Abstract

To explore a possible correlation between susceptibility to Toxoplasma and interferon (IFN)-generating capacity in mice, we compared the levels of serum IFN induced by stimulation with Toxoplasma lysate antigen (TLA) in different strains of Toxoplasma-infected and uninfected mice. Injection of TLA into five strains of mice with chronic Toxoplasma infection resulted in the release of considerable amounts of IFN into the circulation. Most of these IFN activities were acid labile and not neutralized by sheep antiserum against mouse IFN-alpha/beta, indicating that IFN-gamma was the dominant form produced in this system. In contrast, the majority of IFN induced in uninfected mice was characterized as IFN-alpha/beta by their acid stability and antigenicity. The response of IFN production in Toxoplasma-infected and uninfected mice varied quantitatively depending on the mouse strains examined. C57BL/6 mice were found to be the best producers of both IFN-alpha/beta and IFN-gamma, while BALB/c mice were consistently poor producers of both IFN populations. A/J, DBA/2, and C3H/He mice could be roughly classified as intermediate producers of both IFN populations. C57BL/6 and C3H/He mice showed a significant prolongation of mean survival time following primary or secondary infection with Toxoplasma compared to that of BALB/c mice. However, there was no direct correlation between the susceptibility to Toxoplasma and the levels of serum IFN.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2437433     DOI: 10.1111/j.1348-0421.1986.tb03051.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  7 in total

1.  Role of TNF and IL-1 in infections with Toxoplasma gondii.

Authors:  H R Chang; G E Grau; J C Pechère
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

2.  Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells.

Authors:  C N Nagineni; K Pardhasaradhi; M C Martins; B Detrick; J J Hooks
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

Review 3.  Role of gamma interferon in Toxoplasma gondii infection.

Authors:  C S Subauste; J S Remington
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

Review 4.  Protozoan Parasites and Type I IFNs.

Authors:  Sasha Silva-Barrios; Simona Stäger
Journal:  Front Immunol       Date:  2017-01-19       Impact factor: 7.561

5.  Modelling Toxoplasma gondii infection in human cerebral organoids.

Authors:  Hyang-Hee Seo; Hyo-Won Han; Sang-Eun Lee; Sung-Hee Hong; Shin-Hyeong Cho; Sang Cheol Kim; Soo Kyung Koo; Jung-Hyun Kim
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

Review 6.  Influence of the Host and Parasite Strain on the Immune Response During Toxoplasma Infection.

Authors:  Debanjan Mukhopadhyay; David Arranz-Solís; Jeroen P J Saeij
Journal:  Front Cell Infect Microbiol       Date:  2020-10-15       Impact factor: 5.293

7.  Immunostimulating RNA Delivered by P1500 PEGylated Cationic Liposomes Limits Influenza Infection in C57Bl/6 Mice.

Authors:  Elena P Goncharova; Aleksandra V Sen'kova; Innokenty A Savin; Tat'yana O Kabilova; Marina A Zenkova; Valentin V Vlassov; Elena L Chernolovskaya
Journal:  Pharmaceutics       Date:  2020-09-14       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.